US · MOH
Molina Healthcare, Inc.
- Sector
- Healthcare · Medical - Healthcare Plans
- Headquarters
- Long Beach, CA 90802
- Website
- molinahealthcare.com
Price · as of 2025-12-31
$192.70
Market cap 7.93B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $220.28 | +14.31% |
| Intrinsic Value(DCF) | $805.46 | +317.99% |
| Graham-Dodd Method(GD) | $83.36 | -56.74% |
| Graham Formula(GF) | $180.44 | -6.36% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $33.37 | $50.66 | $406.94 | $15.41 | $11.01 |
| 2012 | $33.00 | $61.12 | $1,466.61 | $14.66 | $7.05 |
| 2013 | $37.60 | $73.40 | $939.90 | $20.15 | $19.48 |
| 2014 | $62.26 | $42.56 | $8,901.88 | $22.32 | $70.03 |
| 2015 | $66.24 | $72.41 | $26,898.61 | $33.71 | $142.31 |
| 2016 | $45.73 | $70.81 | $35,864.85 | $19.44 | $4.77 |
| 2017 | $75.49 | $89.03 | $16,643.66 | $0.00 | $0.00 |
| 2018 | $132.55 | $138.02 | $1,143.23 | $75.62 | $35.52 |
| 2019 | $138.20 | $162.60 | $23.73 | $88.46 | $0.00 |
| 2020 | $232.49 | $151.42 | $28.92 | $80.83 | $260.77 |
| 2021 | $313.11 | $225.72 | $3,701.63 | $85.52 | $561.64 |
| 2022 | $261.35 | $222.02 | $7,507.38 | $100.50 | $310.63 |
| 2023 | $392.63 | $277.39 | $4,350.84 | $145.08 | $271.22 |
| 2024 | $327.33 | $280.66 | $3,722.40 | $151.92 | $548.15 |
| 2025 | $152.42 | $220.28 | $4,037.11 | $83.36 | $180.44 |
AI valuation
Our deep-learning model estimates Molina Healthcare, Inc.'s (MOH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $220.28
- Current price
- $192.70
- AI upside
- +14.31%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$805.46
+317.99% upside
Graham-Dodd
$83.36
-56.74% upside
Graham Formula
$180.44
-6.36% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MOH | Molina Healthcare, Inc. | $192.70 | 7.93B | +14% | +318% | -57% | -6% | 16.40 | 1.90 | 0.17 | 7.63 | — | 4.13 | 8.97% | 1.72% | 1.04% | 11.02% | 52.20% | 3.03% | 0.97 | 4.07 | 1.69 | 1.06 | -0.31 | -5632.00% | 1175.00% | -21691.00% | -8.21% | -0.07 | -53.04% | 0.00% | 0.00% | 12.92% | 9.53 | -11.70 | 0.16 | 4.20 |
| ATR | AptarGroup, Inc. | $143.71 | 9.43B | -31% | -59% | -82% | -45% | 23.88 | 3.52 | 2.48 | 12.63 | 366.80 | 7.03 | 29.58% | 13.53% | 10.40% | 15.28% | 11.48% | 8.11% | 0.57 | 9.69 | 1.62 | 1.04 | 1.36 | 651.00% | 542.00% | -1422.00% | 3.19% | 0.49 | 8.43% | 1.29% | 30.80% | 5.18% | 20.55 | 35.05 | 2.78 | 4.13 |
| AVTR | Avantor, Inc. | $9.05 | 6.17B | +191% | -61% | — | — | -11.27 | 1.07 | 0.91 | 68.88 | — | -2.28 | 32.65% | -3.76% | -8.09% | -9.20% | -2.61% | -4.44% | 0.71 | -1.45 | 1.78 | 1.04 | 25.82 | -17500.00% | -341.00% | -2847.00% | 8.29% | 0.45 | 5.24% | 0.00% | 0.00% | 4.92% | -38.81 | 19.30 | 1.46 | 1.37 |
| BIO | Bio-Rad Laboratories, Inc… | $278.44 | 7.52B | +7% | -54% | +41% | -13% | 10.03 | 1.02 | 2.95 | 15.99 | — | 1.14 | 52.01% | 10.47% | 29.42% | 10.84% | 3.01% | 7.62% | 0.21 | 5.52 | 5.62 | 3.90 | 2.10 | -14264.00% | 65.00% | 4072.00% | 4.91% | 1.03 | 5.46% | 0.00% | 0.00% | 3.88% | 28.14 | 20.32 | 2.95 | 3.15 |
| DVA | DaVita Inc. | $156.30 | 10.45B | -3% | -61% | — | -21% | 12.29 | -20.36 | 0.97 | 10.42 | — | -1.57 | 27.00% | 14.74% | 5.47% | -407.09% | 12.61% | 6.21% | -23.12 | 3.66 | 1.29 | 1.19 | 5.41 | -1137.00% | 646.00% | -1063.00% | 9.89% | 0.60 | 10.50% | 0.00% | 0.00% | 13.52% | 13.69 | 21.00 | 2.02 | 1.68 |
| GMED | Globus Medical, Inc. | $95.46 | 12.89B | +11% | +76% | -55% | 0% | 23.57 | 2.77 | 4.31 | 16.77 | 5.58 | 5.30 | 67.41% | 16.33% | 18.30% | 12.29% | 10.63% | 10.19% | 0.03 | — | 4.26 | 2.48 | -0.56 | 42267.00% | 1665.00% | 4530.00% | 4.64% | 1.51 | 14.79% | 0.00% | 0.00% | 3.63% | 25.51 | 20.79 | 4.16 | 12.01 |
| GRFS | Grifols, S.A. | $9.10 | 7.7B | +209% | -64% | — | -49% | 10.85 | 0.82 | 0.67 | 9.37 | 6.98 | -1.08 | 38.75% | 16.53% | 2.18% | 7.89% | 3.72% | 2.09% | 1.71 | 1.54 | 2.66 | 0.96 | 6.13 | 15556.00% | 941.00% | -67929.00% | 11.02% | 0.42 | 3.46% | 0.02% | 0.20% | 28.68% | 11.66 | 26.19 | 1.93 | 0.96 |
| HALO | Halozyme Therapeutics, In… | $69.53 | 8.21B | +26% | +70% | -87% | +68% | 26.42 | 171.48 | 5.99 | 9.10 | — | -5.53 | 78.13% | 58.45% | 22.69% | 153.59% | 93.94% | 13.81% | 0.00 | 45.03 | 4.66 | 3.30 | -0.15 | -2536.00% | 3755.00% | 3762.00% | 7.70% | 3.68 | 109.29% | 0.00% | 0.00% | 22.29% | 10.08 | 12.76 | 5.89 | 3.99 |
| HQY | HealthEquity, Inc. | $76.49 | 6.61B | -8% | -56% | -86% | -60% | 73.84 | 3.38 | 5.95 | 23.56 | 105.02 | -9.68 | 57.73% | 19.18% | 8.06% | 4.66% | 6.98% | 2.92% | 0.52 | 3.79 | 3.06 | 2.65 | 2.41 | 7031.00% | 2003.00% | 7167.00% | 4.73% | 2.17 | 12.30% | 0.00% | 0.00% | 1.70% | 34.57 | 23.55 | 6.63 | 3.98 |
| HSIC | Henry Schein, Inc. | $82.39 | 9.99B | +2% | -60% | -90% | -52% | 24.70 | 3.03 | 0.75 | 13.28 | 342.43 | -4.95 | 29.14% | 5.75% | 3.02% | 11.99% | 9.02% | 3.71% | 1.14 | 5.05 | 1.38 | 0.56 | 3.51 | 721.00% | 403.00% | -1331.00% | 5.83% | 0.22 | 8.87% | 0.00% | 0.00% | 8.65% | 17.63 | 23.32 | 1.01 | 2.86 |
| MASI | Masimo Corporation | $175.35 | 9.42B | — | -60% | — | -71% | -62.06 | 13.04 | 6.16 | 31.37 | — | 16.55 | 61.90% | 20.30% | -9.92% | — | — | — | 0.72 | — | 2.49 | 1.40 | 1.17 | — | — | — | 2.10% | 0.58 | — | 0.00% | 0.00% | 3.87% | 31.51 | 49.38 | 6.40 | 8.77 |
About Molina Healthcare, Inc.
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
- CEO
- Joseph Michael Zubretsky
- Employees
- 18K
- Beta
- 0.49
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($805.46 ÷ $192.70) − 1 = +317.99% (DCF, example).